Sign In
Buy SWAV
$334.75
+0 (+0%)
At Close: Aug 29, 2024
Top 5 Non-Tech Nasdaq Winners of Q1 With More Upside Left
08:56am, Wednesday, 10'th Apr 2024
We have narrowed our search to five high-flying Nasdaq Composite listed non-tech stocks with more upside left. These are: CELH, SWAV, COIN, HOOD, IBKR.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, INRD
10:47pm, Tuesday, 09'th Apr 2024
NEW YORK , April 9, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Shockwave Medical, Inc. - SWAV
08:05pm, Tuesday, 09'th Apr 2024
NEW YORK , April 9, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securit
Shockwave Medical's (SWAV) Reducer Receives Positive Results
12:01pm, Tuesday, 09'th Apr 2024
Shockwave Medical (SWAV) announces the 'real-world' results of the REDUCER-I study, which is intended to collect long-term outcomes on Shockwave Reducer, a novel treatment for refractory angina.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Shockwave Me
Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World' Study
04:03pm, Monday, 08'th Apr 2024
Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary
Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
11:55am, Monday, 08'th Apr 2024
On April 5, 2024, Johnson & Johnson NYSE: JNJ announced its intent to acquire Shockwave Medical Inc. NASDAQ: SWAV for $13.1 billion. Under the terms of the proposed deal, JNJ will pay $335 per share,
Acquisition Watch: Time to Buy Johnson & Johnson (JNJ) or ShockWave Medical's (SWAV) Stock?
04:31pm, Friday, 05'th Apr 2024
News of healthcare behemoth Johnson & Johnson (JNJ) acquiring medical device company ShockWave Medical (SWAV) for $13.1 billion made headlines this morning.
J&J Acquires Shockwave Medical to Boost Its Cardiovascular Treatment Portfolio
12:25pm, Friday, 05'th Apr 2024
Johnson & Johnson (JNJ) announced Friday it was buying Shockwave Medical (SWAV) for $13.1 billion in cash, pushing shares of the maker of cardiovascular catheters to near all-time highs.
Johnson & Johnson to acquire medical device company Shockwave Medical for $13.1B
11:12am, Friday, 05'th Apr 2024
Johnson & Johnson (NYSE:JNJ) (J&J) will bolster its portfolio of medical devices targeting heart disease with its $13.1 billion acquisition of Shockwave Medical. The companies announced on Friday tha
Shockwave Medical Stock Rises After Johnson & Johnson Buyout
11:05am, Friday, 05'th Apr 2024
Shockwave Medical Inc (NASDAQ:SWAV) is in the spotlight today, after blue-chip pharmaceutical giant Johnson & Johnson (JNJ) announced it would buy the company for $12.5 billion, boosting its portfol
Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal
10:33am, Friday, 05'th Apr 2024
The healthcare giant said the addition of the medical-device maker would expand its MedTech cardiovascular portfolio.
Johnson & Johnson Buys Shockwave For $13.1 Billion In Latest Cardio Deal
10:01am, Friday, 05'th Apr 2024
Johnson & Johnson will acquire Shockwave Medical in a deal valued at $13.1 billion, according to a joint statement Friday, the latest acquisition by the pharmaceutical firm over the last two years as
SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson
09:31am, Friday, 05'th Apr 2024
Johnson & Johnson (NYSE: JNJ ) is buying medical device company Shockwave Medical (NASDAQ: SWAV ) for $13.1 billion. Shockwave makes devices that perform Intravascular Lithotripsy.
Johnson & Johnson To Buy Shockwave Medical For $13.1 Billion
08:10am, Friday, 05'th Apr 2024
Johnson & Johnson will pay $13.1 billion, or $335 a share, for Shockwave Medical, which has soared in 2024 in part on takeover speculation.
